Fig. 5. In vivo tumor growth inhibition by aptamosome [SAHA] in LL/2 tumor-bearing models.
(A) Experimental timeline of a designed antitumor study using LL/2 tumor-bearing mice. During the experimental period of 28 d, (B) the body weights and (C) the tumor volume was measured (n = 4). C; *P<0.05 compared with administration of liposome [SAHA] and aptamosome [SAHA].
© 2024 Biomed Sci Letters
